Washington’s life sciences industry injected a $41.2-billion impact into the state’s economy in 2023 — a 6.2% gain over 2022 ...

Absci Corp. research and ratings by Barron's. View ABSI revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Absci Corporation’s ABSI share price has surged by 5.86%, which has investors questioning if this is right time to sell.

Short interest in Absci Corp (NASDAQ:ABSI) increased during the last reporting period, rising from 18.83M to 20.57M. This put 22.75% of the company's publicly available shares short. Short ...

Mother says 'no safe spot' for autistic daughter during Cape Breton ER visit A Cape Breton mother is questioning why emergency department staff didn’t try to help when her autistic daughter began ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

In a report released today, Scott Schoenhaus from KeyBanc maintained a Buy rating on AbSci (ABSI – Research Report), with a price target of ...

KeyBanc raised the firm’s price target on Absci (ABSI) to $9 from $5 and keeps an Overweight rating on the shares. Into Q1 earnings, the firm believes the focus for the HCIT sector will be on ...

Globe Fintech Innovations Inc. (Mynt), the parent company of leading e-wallet GCash, has secured a 16-percent stake of AB Capital Securities Inc. (ABSCI), the stock broking arm of investment house AB ...

These preliminary results are based on management's initial analysis of operations for the quarter ended March 29, 2025, and are subject to further internal review, potential adjustments and review by ...

Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates ...

Absci gained on animal testing phaseout news, but the change has limited near-term impact on its investment case. Read why ...